CompletedPhase 2NCT02781909

Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundació Institut Germans Trias i Pujol
Principal Investigator
Cris Vilaplana, MD, PhD
Fundació Institut Germans Trias i Pujol
Intervention
Ibuprofen(drug)
Enrollment
24 enrolled
Eligibility
16 years · All sexes
Timeline
2016 – 2019

Study locations (2)

Collaborators

National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02781909 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials